http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
- 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
- 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
RISS 인기검색어
- 검색키워드
- 저자 : Shaqayeq Ramezanzade (검색결과 3 건)
- 무료
- 기관 내 무료
- 유료
-
Shaqayeq Ramezanzade,Julian Yates,Frank J. Tuminelli,Seied Omid Keyhan,Parisa Yousefi,Jose Lopez-Lopez 대한악안면성형재건외과학회 2021 Maxillofacial Plastic Reconstructive Surgery Vol.43 No.-
BackgroundZygomatic implants are a treatment option for severely atrophic maxilla. Main textThis study aimed to summarize and evaluate systematic reviews assessing the clinical outcomes of zygomatic implants including survival/failure rate and complications. PubMed-MEDLINE, Google Scholar, LILACS, and the Cochrane Database were searched up to April 2020. Risk of bias assessment was conducted by the AMSTAR tool. Initial searches yielded 175 studies. These were assessed, and following title abstract and full-text evaluation, 7 studies (2 meta-analyses) were included in the final review. According to the AMSTAR tool, 1 was deemed high quality, 4 were classified as medium, and 2 as low quality. The mean AMSTAR score (±SD) was 5.28 of 9 (±2.36) ranging from 2/9 to 9/9. The reported survival rates ranged from 95.2 to 100% except for resected maxillas, which established higher failure rates up to 21.43%. Concerning the complications with the zygomatic implants, various surgical and prosthetic complications were reported with sinusitis being the most frequently observed complication. Zygomatic implants appears to offer a promising alternative to formal bone grafting techniques with lower costs, less complications, less morbidity, shorter treatment times, and comparably high survival rates. ConclusionComplications were rare and usually easy to manage. However, the treatment should be directed by appropriately trained clinicians with noticeable surgical experience.
-
Seied Omid Keyhan,Shaqayeq Ramezanzade,Reza Golvardi Yazdi,Mohammad Amin Valipour,Hamid Reza Fallahi,Madjid Shakiba,Mahsa Aeinehvand 대한악안면성형재건외과학회 2022 Maxillofacial Plastic Reconstructive Surgery Vol.44 No.-
Background: Various techniques with different grafts and implants have been proposed to establish a smooth and symmetric nasal dorsum with adequate function. Broadly, two categories of materials have been used in this regard: alloplastic implant materials and autograft materials. The aim of these meta-analyses is to explore the incidence of complications after dorsum augmentation surgery using alloplastic materials. Materials and methods: After duplication removal 491 papers remained that title and abstract were assessed for eligibility. Regarding the study type, 27 observational studies were included, 21 retrospective and 6 prospective case series. A total of 3803 cases were enrolled in this systematic review and meta-analysis. Result: Twenty-seven articles reported on complications and outcomes of dorsal augmentation rhinoplasty with synthetic materials. In a random-effects model, the weighted mean percentage was 2.75% (95% CI 1.61 to 4.17%). the weighted mean percentage were 1.91% (95% CI 0.77 to 3.54%), 0.72% (95% CI 0.316 to 1.31%), and 0.78% (95% CI 0.43 to 1.24%) respectively. Conclusion: The widely used alloplasts were expanded polytetrafluoroethylene (ePTFE), high-density polyethylene, and silicone. The total rates for complications, infection, deviation, irregularity, hematoma, extrusion, and overcorrection were 2.75%, 1.91%, 0.72%, 0.70%, 0.78%, and 0.49%, respectively. The revision rate, based on the random effects model, was 6.40% with 95%CI (3.84 to 9.57). Trial registration: This meta-analysis was registered at the International Prospective Register of Systematic Reviews (PROSPERO, registration number CRD42 02020 9644).
-
Behzad Houshmand,Seied Omid Keyhan,Hamid Reza Fallahi,Shaqayeq Ramezanzade,Erfan Sadeghi,Parisa Yousefi 대한악안면성형재건외과학회 2022 Maxillofacial Plastic Reconstructive Surgery Vol.44 No.-
Background: The rapidly developed vaccines against the severe acute respiratory syndrome coronavirus 2 carry arisk of provoking side effects. This study aimed to evaluate current vaccination non-serious/serious side effects. Methods: A multicenter electronic questionnaire via an online platform was conducted over a 1-week periodamong vaccinated dental staff and dental students inquiring whether they experienced vaccine-related side-effectsafter vaccine administration. Results: A total of 1205 respondents with a mean age of 39 (SD: 12) were retained for the analyses. The followingvaccines were reported; Gam-COVID-Vac (Sputnik V), ChAdOx1 nCoV-19 (AstraZeneca), BBV152 (Covaxin), or BBIBPCorV(Sinopharm). The majority of respondents received ChAdOx1 nCoV-19 (51.1%) and Gam-COVID-Vac (37.6%). The symptoms most frequently reported after vaccination were fatigue (79%), local pain in the injection site (77.4%),malaise (73%), and body pain (71.1%). Enrollees reported more onset of reactions on 0?12 h (44.1%) and 12?24 h(29.0%) after vaccine administration (p value <0.001). In 75.7%, the side effects last for up to 3 days. Merely 5.5% ofcases reported the presence of side effects after the first week. Individuals with a history of SARSCoV-2 and otherinfections (MERS, influenza, and EBV) were more likely to report a number of unserious systemic side effects. Conclusion: The commonly reported adverse events were in line with similar studies. We have concerns with thefrequency of serious adverse effects. This work necessitates the need for further clinical assessments with largersample sizes.
연관 검색어 추천
이 검색어로 많이 본 자료
활용도 높은 자료
